34 research outputs found

    A Novel On‐Chip Method for Differential Extraction of Sperm in Forensic Cases

    Get PDF
    One out of every six American women has been the victim of a sexual assault in their lifetime. However, the DNA casework backlog continues to increase outpacing the nation\u27s capacity since DNA evidence processing in sexual assault casework remains a bottleneck due to laborious and time‐consuming differential extraction of victim\u27s and perpetrator\u27s cells. Additionally, a significant amount (60–90%) of male DNA evidence may be lost with existing procedures. Here, a microfluidic method is developed that selectively captures sperm using a unique oligosaccharide sequence (Sialyl‐LewisX), a major carbohydrate ligand for sperm‐egg binding. This method is validated with forensic mock samples dating back to 2003, resulting in 70–92% sperm capture efficiency and a 60–92% reduction in epithelial fraction. Captured sperm are then lysed on‐chip and sperm DNA is isolated. This method reduces assay‐time from 8 h to 80 min, providing an inexpensive alternative to current differential extraction techniques, accelerating identification of suspects and advancing public safety

    The Clinical Profile and Electrocardiographic Changes in Scorpion Envenomation

    No full text
    INTRODUCTION: Scorpion stings are a major public health problem in many underdeveloped countries. In India, Many people are stung by the red scorpion (Mesobuthus tamulus) with fatalities in adults and children. Scorpion sting is a life threatening medical emergency of villagers in India. Numerous envenomations are unreported. So true incidence is not known. Among the eighty six scorpion species in India, Mesobuthus tamulus and Palamneus gravimanus are of medical importance. AIMS AND OBJECTIVES: Aim of the study is to assess the clinical profile and electrocardiographic changes caused by scorpion envenomation and to study the severity of scorpion envenomation. METHODS: The study was carried out among patients who admitted in the toxicology ward of Rajiv Gandhi Government General Hospital with history of scorpion sting based on inclusion criteria and exclusion criteria. Total of 87 patients as study subjects and 24 patients as control were selected. Clinical details about the scorpion sting were collected. Complete blood count, Blood sugar, Renal function test, serum CPK, CKMB, CXR, ECG and ECHO taken for both subjects and controls and results were analysed. RESULTS: The study showed male predominance of scorpion study. The incidence was more common between 31 to 40 yrs of age. Scorpion stings more commonly occurs at night. Upper half of the body is common involved in stings. 59.8% of the patients presented with Grade 1 envenomation. 29.9% with Grade 2 and 10.3% with Grade 3 envenomation. Sinus tachycardia was the most common ECG finding. There was no significant difference in clinical presentation with respect to age group and gender. The patients who presented late to the emergency room after scorpion sting were found to have greater morbidity. There was statistical significance in the relationship between ECG changes and biochemical markers like CPK and CK-MB. No deaths observed during the study. CONCLUSION: In this study 36 out of 87cases had ECG changes. Five of the patients presented with pulmonary edema. There was no mortality due to scorpion sting in the present study. There was significant correlation between the time delay and severity of envenomation. This indicates a need for immediate medical care following scorpion sting

    Point-of-care vertical flow allergen microarray assay: proof of concept

    Get PDF
    BACKGROUND:\ud Sophisticated equipment, lengthy protocols, and skilled operators are required to perform protein microarray-based affinity assays. Consequently, novel tools are needed to bring biomarkers and biomarker panels into clinical use in different settings. Here, we describe a novel paper-based vertical flow microarray (VFM) system with a multiplexing capacity of at least 1480 microspot binding sites, colorimetric readout, high sensitivity, and assay time of <10 min before imaging and data analysis. \ud \ud METHOD:\ud Affinity binders were deposited on nitrocellulose membranes by conventional microarray printing. Buffers and reagents were applied vertically by use of a flow controlled syringe pump. As a clinical model system, we analyzed 31 precharacterized human serum samples using the array system with 10 allergen components to detect specific IgE reactivities. We detected bound analytes using gold nanoparticle conjugates with assay time of ≀10 min. Microarray images were captured by a consumer-grade flatbed scanner. \ud \ud RESULTS:\ud A sensitivity of 1 ng/mL was demonstrated with the VFM assay with colorimetric readout. The reproducibility (CV) of the system was <14%. The observed concordance with a clinical assay, ImmunoCAP, was R2 = 0.89 (n = 31). \ud \ud CONCLUSIONS:\ud In this proof-of-concept study, we demonstrated that the VFM assay, which combines features from protein microarrays and paper-based colorimetric systems, could offer an interesting alternative for future highly multiplexed affinity point-of-care testing

    Towards paper-based point of care affinity proteomics

    No full text
    Affinity-based methods such as protein microarrays have come to complement conventional mass/charge-based techniques for proteomic characterization of biological samples. Simultaneous measurement of hundreds or even thousands of serum biomarkers such as antibodies, antigens and other proteins may greatly improve the diagnostic accuracy in a variety of conditions such as autoimmune disorders, infections and several cancers. However, today's technologies for affinity proteomics are cumbersome, require expensive equipment and skilled operators. Here, we present two novel paper-based techniques developed in our lab that aim to bridge the gap between highly multiplexed affinity proteomics and point of care testing

    A lateral flow paper microarray for rapid allergy point of care diagnostics

    Get PDF
    There is a growing need for multiplexed specific IgE tests that can accurately evaluate patient sensitization profiles. However, currently available commercial tests are either single/low-plexed or require sophisticated instrumentation at considerable cost per assay. Here, we present a novel convenient lateral flow microarray-based device that employs a novel dual labelled gold nanoparticle-strategy for rapid and sensitive detection of a panel of 15 specific IgE responses in 35 clinical serum samples. Each gold nanoparticle was conjugated to an optimized ratio of HRP and anti-IgE, allowing significant enzymatic amplification to improve the sensitivity of the assay as compared to commercially available detection reagents. The mean inter-assay variability of the developed LFM assay was 12% CV, and analysis of a cohort of clinical samples (n = 35) revealed good general agreement with ImmunoCAP, yet with a varying performance among allergens (AUC = [0.54-0.88], threshold 1 kU). Due to the rapid and simple procedure, inexpensive materials and read-out by means of a consumer flatbed scanner, the presented assay may provide an interesting low-cost alternative to existing multiplexed methods when thresholds > 1 kU are acceptable
    corecore